Torrent Pharma recalls around 2.30 lakh bottles of high BP treatment tablets from US
The tablets were manufactured by Torrent Pharma in its Mehsana facility in India, the report said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 28, 2019 Category: Pharmaceuticals Source Type: news

Drug exporters wary of tension between India, Pakistan
The Indian pharmaceutical companies exports over USD 140 million to Pakistan with 50 per cent active pharmaceutical ingredients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2019 Category: Pharmaceuticals Source Type: news

Government brings 42 non-scheduled cancer drugs under price control
As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, the release said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2019 Category: Pharmaceuticals Source Type: news

USFDA chief supports generics made in India
The Indian drug makers are finally seeing a recovery with most of their factories being cleared by the US watchdog. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2019 Category: Pharmaceuticals Source Type: news

D G Shah founder of Indian Pharmaceutical Alliance dies at age 77
Mr Shah started the IPA when the Indian pharma companies were trying to find their feet in the global pharma landscape. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2019 Category: Pharmaceuticals Source Type: news

SC exempts painkiller Saridon from the banned list in India
The health ministry had banned the manufacture, sale and distribution of 328 fixed dose combinations (FDCs) of drugs in September last year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2019 Category: Pharmaceuticals Source Type: news

Doctors in Kashmir plan to boycott Macleods, Intas Pharma
Macleods and Intas suspended two medical representatives who posted a Facebook status, considered to be anti-national, post Pulwama attack. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2019 Category: Pharmaceuticals Source Type: news

Income-Tax Department raids Divi's Lab premises
The company said the raids were conducted by the officials of Income-Tax Department under Section 132 of the Income-Tax Act. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2019 Category: Pharmaceuticals Source Type: news

Cipla to acquire 11.71% stake in Wellthy Therapeutics
Goldencross Pharma, a wholly-owned subsidiary of Cipla, has inked an agreement to acquire the minority stake in the Mumbai-based firm for a cash consideration of Rs 10.5 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 18, 2019 Category: Pharmaceuticals Source Type: news

Supreme Court refuses to stay CCI Monsanto probe
CCI has fined both Monsanto Holdings and Mahyco Monsanto Biotech (India). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 18, 2019 Category: Pharmaceuticals Source Type: news

Have received inspection closure report from USFDA for Duvvada facility: Dr Reddy's
"We have received a written communication about the issuance of establishment inspection report (EIR) for FTO VII", said Dr Reddy's. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2019 Category: Pharmaceuticals Source Type: news

Zydus Cadila and Macleods Pharma suspend Kashmiri employees, issue show-cause notices
ET made several phone calls and send SMS to Zydus Cadila, but there was no response. An email query sent to both companies didn ’t elicit any response. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2019 Category: Pharmaceuticals Source Type: news

Pharma giants, Zydus Cadila and Macleods Pharma suspends its Kashmiri employees, issued showcase notice
ET made several phone calls and send SMS to Zydus Cadila, but there was no response. An email query sent to both companies didn ’t elicit any response. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2019 Category: Pharmaceuticals Source Type: news

US Congressmen seek briefing on contaminated drugs from India, China
A bipartisan group of powerful US lawmakers Wednesday sought a congressional briefing on contaminated drugs from India and China used in the treatment of high blood pressure. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 14, 2019 Category: Pharmaceuticals Source Type: news

Traditional knowledge, cheaper drugs on India's agenda for WTO
India has also sought amendment of laws on unilateral action by members on trade issues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches erectile dysfunction treatment drug in US
Tadalafil tablets are a therapeutic equivalent generic version of Adcirca tablets, Dr Reddy's Laboratories said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2019 Category: Pharmaceuticals Source Type: news

Aurobindo acquires Apotex's operations in 5 European countries
The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 11, 2019 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets USFDA nod for drug for patients on dialysis
The approved product is a generic version of Genzyme Corporation's Renagel tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 11, 2019 Category: Pharmaceuticals Source Type: news

Two TB survivors fight Johnson & Johnson monopoly bid
At present, only 2% of over 1.47 lakh patients suffering from multi drug resistant TB in India are currently getting Bedaquiline. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 9, 2019 Category: Pharmaceuticals Source Type: news

United Healthcare Services files complaint against Dr Reddy's US arm
The US-based insurance firm United Healthcare Services has filed a complaint against Dr Reddy's Laboratories and 42 other defendants, involving a total of 30 generic drugs, it said in a regulatory firm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 6, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's Laboratories Ltd appoints Axis Bank ex-MD Shikha Sharma as independent director
She has more than three decades of experience in the financial sector, having begun her career with ICICI Bank Ltd in 1980. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2019 Category: Pharmaceuticals Source Type: news

Culture of ‘bending rules’ in India challenges U.S. drug agency
The FDA didn ’t comment specifically on the reports but cautioned that they don’t all indicate a causal relationship to the drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2019 Category: Pharmaceuticals Source Type: news

Strides to exit investment in Arrow for AUD 394 million
In a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent stake in US-based generics company Vensun Pharmaceuticals Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Natco dares Novartis with new heart drug
According to data from AIOCD PharmaTrac, an agency that closely tracks pharmaceutical sales, Vymada had sales of Rs 68.3 crore for December 2018 on the moving annual turnover (MAT). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Cipla gets USFDA nod for contraceptive injection
Depo-Provera and its generic equivalents had US sales of around USD 159 million for the 12-month period ending November 2018, Cipla further said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 28, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal spray
The drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 28, 2019 Category: Pharmaceuticals Source Type: news

Govt's new proposal: Manufacturer to pay penalty for entire batch if single drug found substandard
There are usually 10,00 to one lakh units in a batch, but the number of drugs - which can be in the form of tablets or liquid - in a batch vary depending on the size of the shipment, a Health Ministry official said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2019 Category: Pharmaceuticals Source Type: news

Use compulsory license and put ceiling to curb prices of patented medicines: Government panel
The committee noted that the prices of patented anti-cancer and antifungal drugs are "on the higher side" and cited the example of Rs 1 lakh being the price for just one injection for cancer treatment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2019 Category: Pharmaceuticals Source Type: news

Lupin gets 6 observations from USFDA for its Pithampur Unit-2
The inspection of Pithampur Unit -2 was carried out by the United States Food and Drug administration (USFDA) between January 14 and January 25, 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 26, 2019 Category: Pharmaceuticals Source Type: news

Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil
For the 12 months to September 2018, DermaSmoothe/FS Topical Oil, 0.01 per cent (scalp oil), achieved annual sales of around USD 14 million, Glenmark said, citing IQVIA sales data. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 24, 2019 Category: Pharmaceuticals Source Type: news

Sun to overhaul business practices to allay concerns
Sun Pharma's domestic formulations biz would be transitioned from Aditya Medisales to a wholly owned arm. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 23, 2019 Category: Pharmaceuticals Source Type: news

50 cancer, rare disease drugs to get cheaper
The decision was taken at a high-level meeting with the Prime Minister ’s Office earlier this month. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 23, 2019 Category: Pharmaceuticals Source Type: news

Sun Pharma replaces domestic formulations distributor with its own subsidiary
Last week, Sun Pharmaceutical asked markets regulator Sebi to look into the issues of certain entities and individuals allegedly adopting unfair trade practices prejudicial to the company's shareholders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2019 Category: Pharmaceuticals Source Type: news

Sun promoters pledged firm's shares for Suraksha
Shanghvi's brother-in-law and realty co owner Valia denies drugmaker stood guarantee for fundraising. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2019 Category: Pharmaceuticals Source Type: news

There is no diversion of funds at all: Sudhir Valia, director, Sun Pharma
Sudhir Valia, brother-in-law of Sun Pharma promoter Dilip Shanghvi, in a telephonic chat with Divya Rajagopal, discusses the issues of Aditya Medisales, raising money through debt papers for Suraksha Realty by involving Shanghvi Finance. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2019 Category: Pharmaceuticals Source Type: news

Wockhardt gets USFDA nod for generic cancer drug
Wockhardt's Imatinib Mesylate tablets are a generic version of Gleevec, marketed in USA and other countries by Novartis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 21, 2019 Category: Pharmaceuticals Source Type: news

Lupin, Sun Pharma, Glenmark recall products in US
Lupin is voluntarily recalling 55,000 vials and 1,60,241 boxes of anti-bacterial drug Ceftriaxone for injection in various strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 20, 2019 Category: Pharmaceuticals Source Type: news

Why Sun Pharma is under a cloud: Decoding Aditya Medisales link
AML ’s arrangement with Sun Pharma was unique because, typically in a pharma business, the distributor is a third party, who buys the stock from the manufacturer and sells it to retailers over a margin fee. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2019 Category: Pharmaceuticals Source Type: news

Sun sinks 13% after reports of 2nd whistleblower letter
Sun complained that such access creates a "great asymmetry in the information circulating between analysts, investors and media, leading to intense speculation". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2019 Category: Pharmaceuticals Source Type: news

Aurobindo acquires 7 oncology drugs from spectrum for $300 million
Nasdaq-listed Spectrum Pharmaceuticals has carved out its commercial business inclusive of seven marketed oncology injectable products, intellectual property and commercial infrastructure. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2019 Category: Pharmaceuticals Source Type: news

Lupin developing new products to treat cancer, other diseases
Sharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to treat chronic kidney diseases and lung cancer. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2019 Category: Pharmaceuticals Source Type: news

Zydus receives final approvals from USFDA for skin ointment, heart medicine
The group also received a final nod for Amlodipine and Atorvastatin Tablets USP that is administered for heart and cholesterol-related cases. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2019 Category: Pharmaceuticals Source Type: news

Hetero launches generic breast cancer treatment drug in India
Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2019 Category: Pharmaceuticals Source Type: news

Lupin recalls over 23,000 bottles of antibiotic drug in US
Drug major Lupin is recalling over 23,000 bottles of an antibiotic drug in the US for being sub-potent, US Food and Drug Administration (USFDA) said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 9, 2019 Category: Pharmaceuticals Source Type: news

Pfizer to stop manufacturing in its Chennai and Aurangabad facilities
The company however said that the exact timing of the exit of the sites is yet to be determined. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 9, 2019 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for antipsychotic drug
The group has more than 243 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 8, 2019 Category: Pharmaceuticals Source Type: news

Lupin gets European Commission nod for myotonia treatment drug
Lupin said it is preparing for the launch of NaMuscla, which will occur in the initial markets of Germany and the UK in the first quarter of 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 8, 2019 Category: Pharmaceuticals Source Type: news

Germ theory: How probiotic products are flying off the shelves
Probiotics gain demand in the new millennium but there is still a lot of grey area around the science of ingesting good bacteria. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 5, 2019 Category: Pharmaceuticals Source Type: news

Drug companies turn to China, Japan after pricing pressure in west
Pharma exports likely to cross $19b; value of exports to US market dips. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 5, 2019 Category: Pharmaceuticals Source Type: news

Sterling Biotech receives NBWs in Rs 8,100-crore bank loan fraud case
The ED has registered the alleged bank fraud case against the firm SBL under sections of the Prevention of Money Laundering Act (PMLA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 5, 2019 Category: Pharmaceuticals Source Type: news